THE ROLE OF BASELINE CONCOMITANT USE OF CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS WITH TNF INHIBITORS IN SPONDYLOARTHRITIS PATIENTS

被引：0

作者：

Akar, S. ^{[1
]}

Kiraz, S. ^{[2
]}

Gercik, O. ^{[1
]}

Ertenli, I. ^{[2
]}

Kucuksahin, O. ^{[2
]}

Dalkilic, E. ^{[3
]}

Bes, C. ^{[4
]}

Kasifoglu, T. ^{[5
]}

Emmungil, H. ^{[6
]}

Koca, S. S. ^{[7
]}

Cinar, M. ^{[2
]}

Yazisiz, V. ^{[8
]}

Dincer, B. Kelesoglu ^{[2
]}

Ates, A. ^{[2
]}

Kanitez, N. Alpay ^{[4
]}

Erten, S. ^{[2
]}

Turan, S. ^{[6
]}

Pehlivan, Y. ^{[3
]}

Oz, B. ^{[7
]}

Bilge, S. Yasar ^{[5
]}

Erden, A. ^{[2
]}

Armagan, B. ^{[2
]}

Coskun, B. N. ^{[3
]}

Kalyoncu, U. ^{[2
]}

机构：

[1] TURKBIO Biol Registry, Izmir, Turkey

[2] TReasure Biol Registry, Ankara, Turkey

[3] TReasure Biol Registry, Bursa, Turkey

[4] TReasure Biol Registry, Istanbul, Turkey

[5] TReasure Biol Registry, Eskisehir, Turkey

[6] TReasure Biol Registry, Edirne, Turkey

[7] TReasure Biol Registry, Elazig, Turkey

[8] TReasure Biol Registry, Antalya, Turkey

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷

关键词：

D O I：

10.1136/annrheumdis-2018-eular.4646

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0297

引用

页码：1012 / 1013

页数：2

共 50 条

[21] Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
Michalis P. Migkos
Evripidis Kaltsonoudis
Eleftherios Pelechas
Vassiliki Drossou
Panagiota G. Karagianni
Athanasios Kavvadias
Paraskevi V. Voulgari
Alexandros A. Drosos
Rheumatology International, 2021, 41 : 903 - 909
[22] Ovarian reserve in patients with spondyloarthritis: impact of biological disease-modifying anti-rheumatic drugs on fertility status
Scrivo, R.
Anastasi, E.
Castellani, C.
Conti, F.
Angeloni, A.
Granato, T.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (09) : 1738 - 1743
[23] USE OF BIOLOGIC OR TARGETED SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AND THE RISK OF LYMPHOMA IN RHEUMATOID ARTHRITIS
Singh, N.
Peterson, A.
Baraff, A.
Bhatti, P.
Gopal, A.
Smith, N.
Barton, J.
Curtis, J.
Li, C.
Weiss, N.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1060 - 1061
[24] Pharmacogenetics of disease-modifying anti-rheumatic drugs
Tanaka, E
Taniguchi, A
Urano, W
Yamanaka, H
Kamatani, N
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (02): : 233 - 247
[25] Use of Biologic or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs and the Risk of Lymphoma in Rheumatoid Arthritis
Singh, Namrata
Peterson, Alexander
Baraff, Aaron
Gopal, Ajay
Smith, Nicholas
Barton, Jennifer
Curtis, Jeffrey
Weiss, Noel
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2381 - 2382
[26] Disease Modifying Anti-Rheumatic Drugs Compliance Study
Vostretsova, Kateryna
Rogers, Pam
Thompson, Darby J. S.
Lacaille, Diane
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S731 - S732
[27] Disease-modifying anti-rheumatic drugs - Cyclosporin
Chaudhuri, K
Torley, H
Madhok, R
BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (09): : 1016 - 1021
[28] Use of disease-modifying anti-rheumatic drugs and cardiovascular events in patients with rheumatoid arthritis
Kaminski, Matthew
Shishehbor, Mehdi H.
Gutierrez, Antonio
Amini, Mohammad R.
Coats, Walter
Moghbelli, Meisam
Askari, Arman T.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A370 - A370
[29] Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
Atzeni, Fabiola
Gerratana, Elisabetta
Francesco Masala, Ignazio
Bongiovanni, Sara
Sarzi-Puttini, Piercarlo
Rodriguez-Carrio, Javier
FRONTIERS IN MEDICINE, 2021, 8
[30] Wound healing outcomes in patients with concomitant autoimmune diseases prescribed disease-modifying anti-rheumatic drugs
Kiene, Julianne
Zhou, Suzanne
Bekeny, Jenna
Rogers, Ashley
Zolper, Elizabeth
Dekker, Paige
Fan, Kenneth
Evans, Karen K.
Mitnick, Carol Deane Benedict
Pasieka, Helena
Attinger, Christopher E.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB12 - AB12

← 1 2 3 4 5 →